| Ytd | 5.94% | |
| 1y | -43.26% |
| Open | 84.08 | Prev Close | 85.33 | Low | 82.27 | High | 85.77 | Mkt Cap | 7.87B |
| Vol | 1.18M | Avg Vol | 2.22M | EPS | 5.20 | P/E | 16.23 | Forward P/E | 14.40 |
| Beta | 0.68 | Short Ratio | 4.66 | Inst. Own | 105.84% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-29 | 50-d Avg | 81.80 | 200-d Avg | 79.81 | 1yr Est | 96.50 |
Sprouts Farmers Market is positioned for a rebound, with a "Buy" rating reiterated following strong
Execution under pre-arranged Rule 10b5-1 plan reduced his direct holdings by 7%, though Sinclair ret
Amundi grew its stake in Sprouts Farmers Market, Inc. (NASDAQ: SFM) by 24.2% during the undefined qu
Consumer interest in organic food is rising. Sprouts sees an opportunity to double its store count i
Sprouts Farmers tops Q2 earnings estimates as new stores, e-commerce and private label offset soft c
Natural-food demand is boosting United Natural Foods, Sprouts Farmers and Simply Good Foods as healt
Top Wall Street analysts changed their outlook on various stocks. Check out the analyst ratings page
Wall Street analysts reshuffled their bets on Thursday as geopolitical fires, a Fed dissent surprise
Top Wall Street analysts changed outlook on top stocks. See all rating changes at 'analyst ratin
Sprouts Farmers Market, Inc. (SFM) Q2 2026 Earnings Call Transcript
Although the revenue and EPS for Sprouts Farmers (SFM) give a sense of how its business performed in
Sprouts Farmers Market NASDAQ: SFM reported second-quarter 2026 results that management said were in
Sprouts Farmers (SFM) came out with quarterly earnings of $1.37 per share, beating the Zacks Consens
PHOENIX--(BUSINESS WIRE)--Sprouts Farmers Market, Inc. (Nasdaq: SFM) today reported results for the
Sprouts Farmers' Q2 growth may have hinged on health-focused demand and loyalty gains, as cautious s
Delta Global Management LP purchased a new stake in shares of Sprouts Farmers Market, Inc. (NASDAQ:
Get a deeper insight into the potential performance of Sprouts Farmers (SFM) for the quarter ended J
ABN Amro Investment Solutions reduced its stake in Sprouts Farmers Market, Inc. (NASDAQ: SFM) by 22.
The latest trading day saw Sprouts Farmers (SFM) settling at $74.61, representing a -1.54% change fr
Boston Common Asset Management LLC lifted its stake in Sprouts Farmers Market, Inc. (NASDAQ: SFM) by
Recently, Zacks.com users have been paying close attention to Sprouts Farmers (SFM). This makes it w
In the latest trading session, Sprouts Farmers (SFM) closed at $75.35, marking a -5.42% move from th
As millions take GLP-1 drugs, packaged food giants face declining volumes while protein brands and s
U.S. stocks slip Tuesday as the 30-year yield surged to an 19-year high near 5.2% and chipmakers tum
US stocks mixed, Dow up 400 pts. Caterpillar, Bandwidth, Everspin, Vistance, IMPINJ, Novocure, Viavi
Wall Street opened the week under heavy pressure as risk sentiment deteriorated on AI-related credit
Here's a look at the earnings calendar for the week ahead, including reports from Opendoor, Carv
Darden, Humana, Rocket Lab, and FactSet led last week's large-cap losers, with declines driven b
A post-earnings surge in Meta Platforms Inc. (NASDAQ:META) and Microsoft Corp.
The Benzinga Stock Whisper Index highlights five stocks seeing increased interest from readers durin
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings
Companies Reporting Before The Bell • BBVA (NYSE:BBVA) is likely to report earnings for its third q
Companies Reporting Before The Bell • Toyota Motor (NYSE:TM) is estimated to report earnings for it
Companies Reporting Before The Bell • TG Therapeutics (NASDAQ:TGTX) is estimated to report quarterl
Companies Reporting Before The Bell • argenx (NASDAQ:ARGX) is expected to report quarterly loss at
Gainers
Companies Reporting Before The Bell • Adtran (NASDAQ:ADTN) is likely to report quarterly earnings a
Gainers
Companies Reporting Before The Bell • Fresh Del Monte Produce (NYSE:FDP) is likely to report qua
Companies Reporting Before The Bell • Seres Therapeutics (NASDAQ:MCRB) is estimated to report qu